Atlas Trials

Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

Clinical trial NCT03812523 · UNKNOWN

Trial details

NCT number
NCT03812523
Sponsor
Southeastern Regional Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chemotherapy-Induced Peripheral Neuropathy
Start date
2019-06-01
Primary completion
2021-02-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.